Guest guest Posted October 4, 2011 Report Share Posted October 4, 2011 Can you please tell us how far along the trials are now for CAL-101 and when, perhaps, ordinary cllers can get it? Thanks, Ellen Dr. Furman wrote: > One aspect that makes CAL-101 such an attractive agent is > that it does not inhibit the PI3Kinase in breast cancer or > other cells outside of the hematopoietic system. CAL-101 > only inhibits the delta isoform, which is not expressed in > solid tumors. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.